O'Donnell M, Ginsberg JS, Kearon C. Thrombosis in the Elderly. In: Halter J, Ouslander J, Tinetti M, Woolard N, High K, Asthana S, eds. Hazards Principles of Geriatrics and Gerontology, McGraw-Hill; 6th Edition, 2008 New York, NY.

Arthur, H.M. & Stone, J.A. (2008). Cardiac Rehabilitation. In K. Heggenhougen & S. Quah (Eds.), International Encyclopedia of Public Health (Vol. 1, pp. 507-511). San Diego, CA: Academic Press.

Devereaux PJ. The term ‘double-blind' leaves readers in the dark. Chapter 18. Cullun N, Ciliska D, Haynes RB, Marks S (eds.). Evidence- based nursing. Hong Kong; Blackwell Publishing Ltd, 2008:130-134.

Guyatt G, Straus S, Meade MO, Kunz R, Cook DJ, Devereaux PJ, Ioannidis J. Therapy (randomized trials). Chapter 6B. Guyatt G, Rennie D, Meade MO, Cook DJ (eds.) Users' guides to the medical literature: A manual for evidence-based clinical practice. 2nd edition. United States of America: McGraw-Hill Companies, Inc. 2008: 67-86.

Montori V, Devereaux PJ, Schunemann H, Meade MO, Cook DJ, Guyatt G. Randomized trials stopped early for benefit: Advanced topics in the validity of therapy trials. Chapter 9.3B. Guyatt G, Rennie D, Meade MO, Cook DJ. (eds.) Users' guides to the medical literature: A manual for evidence-based clinical practice. 2nd edition. United States of America; McGraw-Hill Companies, Inc. 2008: 153-165.

Guyatt G, Montori V, Devereaux PJ, Durieux P. The principle of intention to treat: Advanced topics in the validity of therapy trials. Chapter 9.4B. Guyatt G, Rennie D, Meade MO, Cook DJ. (eds.) Users' guides to the medical literature: A manual for evidence-based clinical practice. 2nd edition. United States of America; McGraw-Hill Companies, Inc. 2008: 167-177.

Ferreira-Gonzalez I, Lacchetti C, Guyatt G, Devereaux PJ. Example numbers needed to treat: Advanced topics in applying the results of therapy trials. Chapter 11.2B. Guyatt G, Rennie D, Meade MO, Cook DJ. (eds.) Users' guides to the medical literature: A manual for evidence-based clinical practice. 2nd edition. United States of America; McGraw-Hill Companies, Inc. 2008: 291-300.

Montori V, Ioannidis J, Jaeschke R, Devereaux PJ, Schunemann H, Bhandari M, Guyatt G. Dealing with misleading presentations of clinical trial results: Advanced topics in applying the results of therapy trials. Chapter 11.3B. Guyatt G, Rennie D, Meade MO, Cook DJ. (eds.) Users' guides to the medical literature: A manual for evidence-based clinical practice. 2nd edition. United States of America; McGraw-Hill Companies, Inc. 2008: 301-315.

McGinn T, Wyer P, Wisnivesky J, Devereaux PJ, Stiell I, Richardson S, Guyatt G. Clinical prediction rules: Advanced topics in diagnosis. Chapter 17.4D. Guyatt G, Rennie D, Meade MO, Cook DJ. (eds.) Users' guides to the medical literature: A manual for evidence-based clinical practice. 2nd edition. United States of America; McGraw-Hill Companies, Inc. 2008: 491-505.

Montori VM, Devereaux PJ, Straus S, Haynes B, Guyatt G. Decision making and the patient: Advanced topics in moving from evidence to action. Chapter 22.2G. Guyatt G, Rennie D, Meade MO, Cook DJ. (eds.) Users' guides to the medical literature: A manual for evidence-based clinical practice. 2nd edition. United States of America; McGraw-Hill Companies, Inc. 2008: 643-661.

2007

McKelvie RS. Heart Failure. Cardiovascular Disorders. Clinical Evidence Concise. London, United Kingdom; BMJ Publishing Group; 2007;01:204-233.

Devereaux PJ. Stable Angina. Chapter 33. Jean Gray (ed) Therapeutic Choices (5th Edition). Ottawa, Canada; Canadian Pharmacists Association, 2007: 432-443.

Ôunpuu S, Yusuf S. Ethnicity and cardiovascular disease. Falk E, Shah PK, de Feyter PJ (eds). Ischemic Heart Disease. Manson Publishing, 2007. Chapter 19. 252-54.

2006

McKelvie RS. The Merck Manual of Diagnosis and Therapy. Cardiovascular Disorders. Sports and the Heart. In: Merck Research Laboratories, Division of Merck and Co., Inc., Whitehouse Station, New Jersey, USA. 18th Edition, 2006. Section 7(82):766-769.

Pogue J, Sackett D, Wyse DG, Yusuf S. Data monitoring in the Heart Outcomes Prevention Evaluation and the Clopidogrel in Unstable Angina to prevent Recurrent ischemic Events trials: avoiding important information loss. DeMets D, Furberg CD, Friedman LM (eds). Data monitoring in clinical trials: a case studies approach. Springer 2006. Chapter 10. 158-165.

Pogue J, Yusuf S. Data monitoring in the Randomized Evaluation of Strategies for Left Ventricular Dysfunction Pilot Study: when reasonable people disagree. DeMets D, Furberg CD, Friedman LM (eds). Data monitoring in clinical trials: a case studies approach. Springer 2006. Chapter 26. 330-336.

2005

Bates SM, O'Donnell MJ, Hirsh J. Antithrombotic Therapy in Venous Thrombosis and Pulmonary Embolism. In Kristensen SD, DeCaterina R, Molitermo D, eds. Therapeutic Strategies in Thrombosis (2005), Clinical Publishing; 2nd Edition, London.

McKelvie R.S. Heart Failure. In: Skinner, J.S., editor. Exercise Testing and Exercise Prescription for Special Cases: Theoretical Basis and Clinical Application. Lippincott Williams & Wilkins (Third Edition); 2005. Chapter 21, p.323-336.

McKelvie RS. Heart Failure. Cardiovascular Disorders. Clinical Evidence Concise. London, United Kingdom: BMJ Publishing Group; 2005;14:1-2.

Arthur, H.M., & Flanagin, A. (2005). Bias and random error. In A. DiCenso G. Guyatt & D. Ciliska (Eds.), Evidence-based nursing: A guide to clinical practice (1st ed., pp. 397-406). St. Louis, MO: Elsevier Inc.

Arthur, H.M., & Nelson, A. (2005). Prognosis. In A. DiCenso G. Guyatt & D. Ciliska (Eds.), Evidence-based nursing: A guide to clinical practice (1st ed., pp. 108-119). St. Louis, MO: Elsevier Inc.

Marshall DA, Demers C, O'Brien BJ. Economic Evaluation. In Dicenso A, Ciliska D, Guyatt G, (Eds). Evidence-Based Nursing: A Guide to Clinical Practice. Elsevier Publishing & AMA, Philadelphia 2005 Chapter 18, pages 298-317.

Anand S, Lonn E, Yusuf. S. The Secondary Prevention of Cardiovascular Disease. Marmot & Elliott eds. Coronary Heart Disease Epidemiology 2nd Edition. London: Oxford University Press 2005;769-791.

Morillo CA. Utilidad del masaje del seno carotideo y la prueba de mesa basculante en la evaluacion del pacinte con sincope (Utility of carotid sinus massage and head up tilt test for the assessment of patients with unexplained syncope). In Morillo CA, Medina LE (Eds). Sincope (Syncope), Sociedad Colombiana de Cardiologia, Bogota DC, 2005; pp.33-37.

Baranchuk A, Morillo CA. Guidelines for the Prevention of Sudden Cardiac Death: Filling the gap, In Gulizzia M (Ed), Emerging Pathologies in Cardiology, Springer-Verlag, Milan, 2005, pp.223-230.

Morillo CA, Baranchuk A. Muerte Subita (Sudden Death). In Charria D, Melgarejo E (eds), 2nda Edicion Texto de Cardiologia (2nd Edition Cardiology Textbook), Bogota, SCC. 2005, pp:

Morillo CA, Baranchuk A, Guzman JC. Sindromes de Intoleracia Ortostatica (Orthostatic Intolerance Syndromes). In Charria D, Melgarejo E (eds), Texto de Cardiologia, Bogota, SCC. 2005

Morillo CA, Baranchuk A, Guzman JC. Evaluacion y Manejo del Paciente con Sincope (Evaluation and Assessment of Syncope). In Charria D, Melgarejo E (eds), Texto de Cardiologia, Bogota, SCC. In press.

Baranchuk A, Morillo CA. Central Nervous System and Sudden Cardiac Death: Is there a Link? In Cruz F, Maia IG (Eds); Arritmias Cardiacas, Revinter, Rio de Janeiro, Brazil, 2005;In Press.

Morillo CA, Guzmán JC, Baranchuk A. New pathophysiologic insights on the Mechanisms of neurally mediated syncope. In Cruz F, Maia IG (Eds); Arritmias Cardiacas, Revinter, Rio de Janeiro, Brazil, 2005;In Press.

2004

Heckman GA, McKelvie RS, Turpie ID. Heart Failure in the Frail elderly. In: Turpie ID, Heckman GA, ed. Aging Issues in Cardiology. Kluwer Academic Publishers; Boston 2004. Chapter 7, p. 139-162.

Demers C, McKelvie RS. Heart Failure Management Programs. In: Turpie ID, Heckman GA, ed. Aging Issues in Cardiology. Kluwer Academic Publishers; Boston 2004. Chapter 8, p. 163-180.

McKelvie RS. Heart Failure. In: Godlee F, Tovey D, Bedford M, Amore LGC, et al, editors. Clinical Evidence. London, United Kingdom: BMJ Publishing Group; 2004;11:122-48.

McKelvie RS. Cardiovascular Disorders: Heart Failure. In: Godlee F, Tovey D, Bedford M, Amore LGC, et al, editors. Clinical Evidence Concise. London, United Kingdom: BMJ Publishing Group; 2004;12:19-22.

Stone, J. A., Arthur, H.M., Austford, L., & Blair, T. (2004). Introduction to cardiac rehabilitation. In J. A. Stone & H. M. Arthur (Eds.), Canadian guidelines for cardiac rehabilitation and cardiovascular disease prevention: Enhancing the science, refining the art (2nd ed., pp. 2-14). Winnipeg, MB: Canadian Association of Cardiac Rehabilitation.

Stone, J. A., Arthur, H.M., Drouin, D., Feldman, R., Fodor, G. Friesen, M., Genest, J., Gledhill, N., Harris, S. Katzmarzyk, P., Leiter, L., Prior, P., & Sharratt, M. (2004). Risk modification and secondary prevention. In J.A. Stone & H.M. Arthur (Eds.), Canadian guidelines for cardiac rehabilitation and cardiovascular disease prevention: Enhancing the science, refining the art (2nd ed., pp. 115-191). Winnipeg, MB: Canadian Association of Cardiac Rehabilitation.

Lowensteyn, I., Grace, S., Stone, J.A., Arthur, H.M. (2004). Research opportunities in cardiac rehabilitation. In J.A. Stone & H.M. Arthur (Eds.), Canadian guidelines for cardiac rehabilitation and cardiovascular disease prevention: Enhancing the science, refining the art (2nd ed., pp. 310-315). Winnipeg, MB: Canadian Association of Cardiac Rehabilitation.

Stone, J.A., Arthur, H.M. (2004). The future. In J. A. Stone & H. M. Arthur (Eds.), Canadian guidelines for cardiac rehabilitation and cardiovascular disease prevention: Enhancing the science, refining the art (2nd ed., pp. 316-318). Winnipeg, MB: Canadian Association of Cardiac Rehabilitation.

Didyk N, Morillo CA. Falls, dizziness and syncope in the very old (Chapter 6). In Heckman G, Turpie I (Eds); Aging Issues in Cardiology, Kluwer Academic Publishers, Norwell, Massachussets, USA. 2004, pp:115-133.

Mehta SR, Yusuf S. Treatment trials: treatment of acute myocardial ischemia: aspirin and thienopyridines. Manson JE, Buring JE, Ridker PM, Gaziano JM. (eds). Clinical trials in heart disease (a companion to Braunwald's Heart Disease). 2nd ed. Saunders. 2004. Chapter 5. 33-44.

2003 (Back to top)

Devereaux PJ, Haynes RB, Yusuf S. What is evidence-based cardiology? Chapter 1. Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ. (eds.) Evidence based Cardiology (2nd Edition). London, England; BMJ Books, 2003: 3-13.

Devereaux PJ. Angina pectoris. Chapter 25. Jean Gray (ed) Therapeutic Choices (4th Edition). Ottawa, Canada; Canadian Pharmacists Association, 2003: 272-283.

Lonn E, Smieja M, Yusuf S. Emerging approaches in cardiovascular prevention. Chapter 18. Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ (eds.). Evidence Based Cardiology. 2nd ed. BMJ Books. 2003: 219-230.

Anand S, Hirsh J: Treatment of acute coronary syndromes: which heparin and for how long? In: Bono D, Sobel B, editors. Acute Coronary Syndromes. London: Blackwell Science Ltd;2001.p.203-214.

Mehta SR. Acute Myocardial Infarction. In: British Medical Journal/American College of Physicians Clinical Evidence 2001. British Medical Journal Publishing Group: London, 2001

Capes S, Anand S. What is Type 2 Diabetes. In: Gerstein H, Haynes R, editors. Evidence Based Diabetes Care. Hamilton. B.C. Decker Inc. 2001 pg. 151-163.

Haynes RB, Gerstein HC. Chapter 1: What Evidence (pages 1-5)? In Gerstein HC, Haynes RB eds. Evidence Based Diabetes Care. B.C. Decker Inc. 2001.

Gerstein HC. Chapter 6: What is Diabetes (pages 62-67)? In Gerstein HC, Haynes RB eds. Evidence Based Diabetes Care. B.C. Decker Inc. 2001.

Gerstein HC. The plasma glucose level - A continuous risk factor for vascular disease in both diabetic and nondiabetic people. In: Angel A, Dhalla N, Pierce G, Singal P. eds. Diabetes and Cardiovascular Disease: From Molecular Processes to Health Policy. Kluwer Academic/Plenum. 2001. New York.

Lonn EM. Secondary Prevention of Ischemic cardiac Events. In: Clinical Evidence. A Compendium Of The Best Available Evidence For Effective Health Care. BMJ Publishing Group 1999. pp 502-515. Updated in 2000; updated in 2001.

O'Donnell MJ, Oral Anticoagulant Therapy in the Elderly. In: Heckman G, Turpie I, (2003). Geriatric Cardiology. 1^st Edition, Hamilton.

Eikelboom JW, Mehta SR, Yusuf S. Hirudin for acute coronary syndromes. In: New Therapeutic Agents in Thrombosis and Thromblysis. Second Edition. Edited by A.A. Sasahara, J. Loscalzo. Marcel Decker, Inc. 2003; Chapter 13: 201-216.

Mehta SR, Yusuf S. Aspirin and thienopyridines. In: Clinical Trials in Heart Disease, Second Edition. Edited by E. Braunwald. W. B. Saunders Company, 2003; Chapter 5: 33-44.

McKelvie RS, Benedict CR, Yusuf S. Prevention of Congestive Heart Failure and Treatment of Asymptomatic Left Ventricular Dysfunction. In: Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ, editors. Evidence Based Cardiology. London, England: British Medical Journal Publishing Group (Second Edition); 2003. p. 643-58.

Teo KK, Haykowsky M, Demers C, McKelvie RS. Benefits of exercise in patients with congestive heart failure. In: Dhalla NS, Chockalingam A, Berkowitz HI, Singal PK, ed. Frontiers in Cardiovascular Health. Kluwer Academic Publishers, Boston 2003 Chapter 37, pages 507-518.

Demers C, McKelvie RS. Congestive Heart Failure Management Programs. In Aging issues for Cardiologists. Boston: Kluwer Academic Publishers, Boston 2003 Chapter 8, pages 163-180.

Devereaux PJ. Angina pectoris. Chapter 25. Jean Gray (ed) Therapeutic Choices (4th Edition). Ottawa, Canada; Canadian Pharmacists Association, 2003: 272-283.

Anand SS, Ôunpuu S, Yusuf S. Ethnicity and cardiovascular disease. Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ (eds.). Evidence Based Cardiology. 2nd ed. BMJ Books. 2003: 259-278.

Rihal CS, Raco D, Gersh BJ, Yusuf S. Impact of revascularization procedures in chronic coronary artery disease on clinical outcomes: a critical review of the evidence. Chapter 27. Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ (eds.). Evidence Based Cardiology. 2nd ed. BMJ Books. 2003: 339-359.

McKelvie RS, Benedict CR, Yusuf S. Prevention of congestive heart failure and treatment of asymptomatic left ventricular dysfunction. Chapter 45. Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ (eds.). Evidence Based Cardiology. 2nd ed. BMJ Books. 2003: 643-658.

Fallen EL, Yusuf S. Clinical applications of external evidence. Chapter 63. Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ (eds.). Evidence Based Cardiology. 2nd ed. BMJ Books. 2003: 889-891.

Held PH, Teo KK, Yusuf S. Effects of medical therapies on acute myocardial infarction and unstable angina pectoris. Topol EJ (ed). Textbook of Interventional Cardiology. 4th ed. Saunders. 2003. Chapter 3. 65-78.

2002 (Back to top)

Capes SE, Gerstein HC. Section 8. The Endocrine System - Thyroiditis (pages 660-663). In Rakel RE, Bope ET eds. Conn's Current Therapy. WB Saunders Co. Philadelphia 2002.

2001 (Back to top)

Gerstein HC, Malmberg KA, Capes S, Yusuf S. Chapter 24: Cardiovascular Diseases (pages 488-514). In Gerstein HC, Haynes RB eds. Evidence-Based Diabetes Care. BC Decker Inc. Hamilton 2001.

Anand S, Yusuf S: Ethnic Variations and Cardiovascular Disease. In: Shetty P, editor. Health and Ethnicity. London: Taylor and Francis Books Ltd;2001.p.164-186.

Yusuf S, Ounpuu S, Anand S. The Global epidemic of atherosclerotic cardiovascular disease. Chapter 4. Opie LH and Yellon DM (eds). Cardiology at the limits IV. Stanford Writers: Cape Town, 2001:61-68.

Anand S, Hirsh J: Treatment of acute coronary syndromes: which heparin and for how long? In: Bono D, Sobel B, editors. Acute Coronary Syndromes. London: Blackwell Science Ltd;2001.p.203-214.

Mehta SR. Acute Myocardial Infarction. In: British Medical Journal/American College of Physicians Clinical Evidence 2001. British Medical Journal Publishing Group: London, 2001

Capes S, Anand S. What is Type 2 Diabetes. In: Gerstein H, Haynes R, editors. Evidence Based Diabetes Care. Hamilton. B.C. Decker Inc. 2001 pg. 151-163.

Haynes RB, Gerstein HC. Chapter 1: What Evidence (pages 1-5)? In Gerstein HC, Haynes RB eds. Evidence Based Diabetes Care. B.C. Decker Inc. 2001.

Gerstein HC. Chapter 6: What is Diabetes (pages 62-67)? In Gerstein HC, Haynes RB eds. Evidence Based Diabetes Care. B.C. Decker Inc. 2001.

2000 (Back to top)

Mehta SR, Yusuf S. Acute Myocardial Infarction. In: British Medical Journal/American College of Physicians Clinical Evidence 2000. British Medical Journal Publishing Group: London, 2000

1999 (Back to top)

Lonn EM, Yusuf S. Pharmacologic Secondary Prevention of Coronary Artery Disease in Women. In: Coronary Artery Disease in Women: What all Physicians Need To Know (P Charney Ed)New York: American College of Physicians-American Society of Internal Medicine; 1999. pp 535-572.

Anand S. Cardiovascular Disease among South Asians â€" A Canadian Perspective. In Coronary Artery Disease in Indians; A Global Perspective. K.K Shethi editor. New Delhi: Stancare Inc. 1999: Chapter 4:44-49

Mehta SR, Yusuf S. Acute Myocardial Infarction. In: British Medical Journal/American College of Physicians Clinical Evidence 99. British medical Journal Publishing Group: London, 1999.

Baker B, Anand S. Coronary Heart Disease. In Health Psychology: A Cultural Approach. S. Kazarian, editor. Prentice-Hall Canada Inc. 1999

Gerstein HC. Chapter 2: Epidemiology of Heart Disease in Diabetes (pages 3-12). In Ryden L, Stanley WC eds. The Diabetic Coronary Patient. Science Press Ltd., London, 1999.

Hunt DL, Gerstein HC. Foot Ulcers in Diabetes (pages 26-31). In: Clinical Evidence: a Compendium of the Best Available Evidence for Effective Health Care. BMJ Publishing Group, London, 1999.

1998 (Back to top)

Lonn EM, Yusuf S. Emerging Approaches in Cardiovascular Prevention. In: Evidence Based Cardiology. (Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ) UK: British Medical Journal Publishing Group; 1998. pp 286-302.

S. Anand, S. Yusuf: Ethnicity and cardiovascular disease: In: Yusuf S, Cairn J, Camm A, Fallen E, Gersh B, editors. Evidence Based Cardiology. London: BMJ;1998.p.329-352.

S. Anand, S. Yusuf. Risk stratification for vascular disease. In Critical Decisions in Thrombosis and Haemostasis. J.S. Ginsberg editor. Hamilton: B.C. Decker Inc 1998: Chapter 30: 179-189.

Ounpuu S, Yusuf S, Anand S. Global burden of cardiovascular disease: A review of the evidence. In Coronary Artery Disease in Indians: A Global Perspective. Sethi KK (Ed). Cardiological Society of India, Mumbai, India: 1988.

Shin AY, Anand SS, Wall C, Tu JV, Yusuf S, Naylor CD. Ethnoracial Origins and Heart Disease. Chapter 12, December 1998 Cardiac Atlas.

Gerstein HC. Chapter 16: Glucose Abnormalities and Cardiovascular Disease: Dysglycemia as an Emerging Cardiovascular Risk Factor (pages 239-250). In: Yusuf S ed. Evidence Based Cardiology. BMJ Books, London, 1998.

Gerstein HC, Singer W, Asa SL: Chapter 32: Clinicopathologic Correlations (pages 895-932). In: Kovacs K, Asa SL eds. Functional Endocrine Pathology, 2nd edition. Blackwell Scientific Publications, Malden, 1998.

1997 (Back to top)

Gerstein HC. Endocrinology (Second Editor). In: Levine M, Lexchin J, Pellizari R eds. Drugs of Choice, 2nd edition. Canadian Medical Association, Ottawa, 1997.

1996 (Back to top)

Lonn E, Bosch J, Flather M, Yusuf S, on behalf of the Canadian Cardiovascular Collaboration. Vascular and anti-atherosclerotic effects of angiotensin converting enzyme inhibitors. In: Advanced issues in prevention and treatment of atherosclerosis. UK: Euromed Communications Ltd; 1996. pp 63-82.

Lonn EM, Gerstein HC, Bosch J, Yusuf S: New approaches to prevention of atherosclerosis - an overview of the Heart Outcomes Prevention Evaluation Study. In: New horizons in the management of post myocardial infarction patients. UK: Euromed Communications Ltd; 1996. pp 39-55.

S. Anand, S. Yusuf. Current status of prevention of atherosclerosis. In Advanced issues in prevention and treatment of atherosclerosis. Salim Yusuf, Lars Wilhelmsen editors. United Kingdom: Hoechst Aktiengesellschaft, c1996.

1994 (Back to top)

JHA P, Lonn E, Flather M, Bosch J, Yusuf S, on behalf of the Canadian Cardiovascular Collaboration. Rationale for the HOPE (Heart Outcomes PRevention Evaluation) study. In: ACE-Inhibitors in high risk patients. UK: Euromed Communications Ltd; 1994. pp 89-103.

1993 (Back to top)

Foster FS, Lockwood GR, Ryan LK, Liu P, Lonn E, Gottlieb AI. High frequency ultrasound vascular imaging. In: Frontiers in cardiovascular imaging. New York: Raven Press; 1993. p. 261-274.